DE69419324D1 - Verfahren zur herstellung eines fibrinogen,faktor xiii und fibronectin enthaltenden biologischen klebstoffes - Google Patents

Verfahren zur herstellung eines fibrinogen,faktor xiii und fibronectin enthaltenden biologischen klebstoffes

Info

Publication number
DE69419324D1
DE69419324D1 DE69419324T DE69419324T DE69419324D1 DE 69419324 D1 DE69419324 D1 DE 69419324D1 DE 69419324 T DE69419324 T DE 69419324T DE 69419324 T DE69419324 T DE 69419324T DE 69419324 D1 DE69419324 D1 DE 69419324D1
Authority
DE
Germany
Prior art keywords
proteins
fibronectin
factor xiii
biological adhesive
thrombin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69419324T
Other languages
English (en)
Other versions
DE69419324T2 (de
Inventor
Trung Bui-Khac
Lise Lavoie
St Picq Dominique Michel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Haemacure Corp Canada
Original Assignee
Haemacure Corp Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25683079&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69419324(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Haemacure Corp Canada filed Critical Haemacure Corp Canada
Application granted granted Critical
Publication of DE69419324D1 publication Critical patent/DE69419324D1/de
Publication of DE69419324T2 publication Critical patent/DE69419324T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043—Mixtures of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69419324T 1993-02-23 1994-02-28 Verfahren zur herstellung eines fibrinogen,faktor xiii und fibronectin enthaltenden biologischen klebstoffes Expired - Lifetime DE69419324T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/021,302 US5395923A (en) 1993-02-23 1993-02-23 Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"
PCT/CA1994/000105 WO1995023167A1 (en) 1993-02-23 1994-02-28 Process for the obtention of a biological adhesive comprising fibrinogen, factor xiii and fibronectin

Publications (2)

Publication Number Publication Date
DE69419324D1 true DE69419324D1 (de) 1999-08-05
DE69419324T2 DE69419324T2 (de) 2000-03-02

Family

ID=25683079

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69419324T Expired - Lifetime DE69419324T2 (de) 1993-02-23 1994-02-28 Verfahren zur herstellung eines fibrinogen,faktor xiii und fibronectin enthaltenden biologischen klebstoffes

Country Status (12)

Country Link
US (1) US5395923A (de)
EP (1) EP0748337B1 (de)
JP (1) JP3492694B2 (de)
AT (1) ATE181738T1 (de)
AU (1) AU678439B2 (de)
CA (1) CA2113660C (de)
DE (1) DE69419324T2 (de)
DK (1) DK0748337T3 (de)
ES (1) ES2135564T3 (de)
NO (1) NO317699B1 (de)
RU (1) RU2130946C1 (de)
WO (1) WO1995023167A1 (de)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197325B1 (en) 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6117425A (en) * 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
US5792835A (en) * 1991-09-05 1998-08-11 Baxter International Inc. Method of preparing a topical fibrinogen complex
SE9301582D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Purification of plasma proteins
US5585007A (en) * 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant
JPH11502431A (ja) * 1995-01-16 1999-03-02 バクスター インターナショナル インコーポレイテッド 手術後の癒着を防止するための架橋化フィブリンの自己支持シート様材料
JPH08333277A (ja) * 1995-06-05 1996-12-17 Hoechst Japan Ltd ヒト血液凝固第ｘｉｉｉ因子の安定化された水性液製剤
EP0917444A1 (de) 1996-07-12 1999-05-26 Baxter Travenol Laboratories, Inc. Fibrinliefervorrichtung und verfahren zur erzeugung von fibrin auf einer fläche
US6566406B1 (en) * 1998-12-04 2003-05-20 Incept, Llc Biocompatible crosslinked polymers
AU4648697A (en) * 1996-09-23 1998-04-14 Chandrashekar Pathak Methods and devices for preparing protein concentrates
US8003705B2 (en) * 1996-09-23 2011-08-23 Incept Llc Biocompatible hydrogels made with small molecule precursors
JP2001508447A (ja) * 1997-01-08 2001-06-26 ブリストル−マイヤーズ スクイブ カンパニー 温度制御手段を備えた遠心分離装置
US6132598A (en) * 1997-01-08 2000-10-17 Bristol-Myers Squibb Company Centrifuge apparatus with temperature control means
US6630137B1 (en) 1997-04-28 2003-10-07 Eli Lilly And Company Activated protein C formulations
US6159468A (en) * 1997-04-28 2000-12-12 Eli Lilly And Company Activated protein C formulations
US5900270A (en) * 1997-09-22 1999-05-04 Cobe Laboratories, Inc. Technique for testing and coating a microporous membrane
US5981254A (en) * 1997-10-30 1999-11-09 Haemacure Corporation Process for producing thrombin from plasma
WO1999025782A2 (en) 1997-11-17 1999-05-27 Haemacure Corporation Fibrin sealants or adhesives comprising a hyaluronic acid derivative material
BE1012536A3 (fr) 1998-11-04 2000-12-05 Baxter Int Element muni d'une couche de fibrine sa preparation et son utilisation.
US6310036B1 (en) 1999-01-09 2001-10-30 Last Chance Tissue Adhesives Corporation High strength, Bio-compatible tissue adhesive and methods for treating vigorously bleeding surfaces
DE60027695T2 (de) 1999-02-12 2007-04-26 Baxter Ag Verfahren zur herstellung von fibrinogen und fibronectin sowie proteinzusammesetzungen, welche damit herstellbar sind
JP4771594B2 (ja) * 1999-02-12 2011-09-14 バクスター アクチェンゲゼルシャフト フィブリノーゲンおよびフィブロネクチンをベースとする製剤を生成するための方法ならびにこの方法により入手可能なタンパク質組成物
US6610043B1 (en) 1999-08-23 2003-08-26 Bistech, Inc. Tissue volume reduction
US7654998B1 (en) 1999-08-23 2010-02-02 Aeris Therapeutics, Inc. Tissue volume reduction
EP1240200B1 (de) 1999-12-23 2009-06-03 Csl Limited Abtrennung von fibrinogen von plasmaproteasen
US7204981B2 (en) * 2000-03-28 2007-04-17 Eli Lilly And Company Methods of treating diseases with activated protein C
WO2001089558A2 (en) 2000-05-24 2001-11-29 Eli Lilly And Company Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states
US6648911B1 (en) 2000-11-20 2003-11-18 Avantec Vascular Corporation Method and device for the treatment of vulnerable tissue site
WO2003071986A2 (en) * 2002-02-22 2003-09-04 Control Delivery Systems, Inc. Method for treating otic disorders
AU2003213146A1 (en) * 2002-03-08 2003-09-22 Eli Lilly And Company Activated protein c formulations
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7374678B2 (en) * 2002-05-24 2008-05-20 Biomet Biologics, Inc. Apparatus and method for separating and concentrating fluids containing multiple components
US7832566B2 (en) * 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
DE10392686T5 (de) * 2002-05-24 2005-07-07 Biomet Mfg. Corp., Warsaw Vorrichtung und Verfahren zum Trennen und Konzentrieren von Flüssigkeiten, welche mehrere Komponenten enthalten
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
GB0216001D0 (en) 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
US7135027B2 (en) 2002-10-04 2006-11-14 Baxter International, Inc. Devices and methods for mixing and extruding medically useful compositions
US9358318B2 (en) 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
US20060258995A1 (en) * 2004-10-20 2006-11-16 Pendharkar Sanyog M Method for making a reinforced absorbable multilayered fabric for use in medical devices
DK1809342T3 (en) * 2004-10-20 2015-08-17 Ethicon Inc absorbable hemostat
EP1848474B1 (de) * 2005-02-07 2013-06-12 Hanuman LLC Vorrichtung und verfahren mit blutplättchenreichem plasmakonzentrat
EP2666494B1 (de) * 2005-02-07 2018-01-17 Hanuman LLC Vorrichtung und Verfahren für blutplättchenreiches Plasmakonzentrat
US7866485B2 (en) 2005-02-07 2011-01-11 Hanuman, Llc Apparatus and method for preparing platelet rich plasma and concentrates thereof
CN1911440A (zh) * 2005-08-08 2007-02-14 上海莱士血制品有限公司 一种用于形成纤维蛋白膜的试剂盒及其应用
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8430813B2 (en) * 2006-05-26 2013-04-30 Depuy Spine, Inc. Illuminated surgical access system including a surgical access device and integrated light emitter
AU2008214319A1 (en) * 2007-02-06 2008-08-14 Incept, Llc Polymerization with precipitation of proteins for elution in physiological solution
US20090227981A1 (en) * 2007-03-05 2009-09-10 Bennett Steven L Low-Swelling Biocompatible Hydrogels
US20090227689A1 (en) * 2007-03-05 2009-09-10 Bennett Steven L Low-Swelling Biocompatible Hydrogels
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
JP5479319B2 (ja) * 2007-04-12 2014-04-23 バイオメット・バイオロジックス・リミテッド・ライアビリティ・カンパニー ブイ式懸濁液分画システム
US8067028B2 (en) * 2007-08-13 2011-11-29 Confluent Surgical Inc. Drug delivery device
EP2259774B1 (de) 2008-02-27 2012-12-12 Biomet Biologics, LLC Verfahren und zusammensetzungen zur abgabe eines interleukin-1-rezeptor-antagonisten
WO2009111338A1 (en) * 2008-02-29 2009-09-11 Biomet Manufacturing Corp. A system and process for separating a material
US8012077B2 (en) * 2008-05-23 2011-09-06 Biomet Biologics, Llc Blood separating device
CN102395401B (zh) 2009-02-12 2015-08-19 因赛普特有限责任公司 经由水凝胶塞的药物递送
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8313954B2 (en) * 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
RU2561676C1 (ru) * 2014-04-07 2015-08-27 Государственное Бюджетное Образовательное Учреждение Высшего Профессионального Образования "Амурская Государственная Медицинская Академия" Министерства Здравоохранения Российской Федерации Способ получения клеящей массы
US9932388B2 (en) 2014-11-13 2018-04-03 Hemarus Therapeutics Limited Chromatographic process for producing high purity fibrinogen and thrombin
US9713810B2 (en) 2015-03-30 2017-07-25 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US9757721B2 (en) 2015-05-11 2017-09-12 Biomet Biologics, Llc Cell washing plunger using centrifugal force

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2826533A (en) * 1954-03-15 1958-03-11 Cutter Lab Stable fibrinogen solutions and method for producing same
JPS5598196A (en) * 1979-01-16 1980-07-25 Meito Sangyo Kk Fractionation of fibrinogen or its constituents and their use
AT359652B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
AT390001B (de) * 1984-09-28 1990-03-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern
DE3622642A1 (de) * 1986-07-05 1988-01-14 Behringwerke Ag Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung
US4876241A (en) * 1987-05-22 1989-10-24 Armour Pharmaceutical Company Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
FR2618784B1 (fr) * 1987-07-30 1990-04-06 Lille Transfusion Sanguine Concentre de proteines coagulables par la thrombine, son procede d'obtention et son utilisation a titre de colle biologique
US4877608A (en) * 1987-11-09 1989-10-31 Rorer Pharmaceutical Corporation Pharmaceutical plasma protein formulations in low ionic strength media
US5030215A (en) * 1990-01-03 1991-07-09 Cryolife, Inc. Preparation of fibrinogen/factor XIII precipitate
WO1992013495A1 (en) * 1991-02-07 1992-08-20 Fibratek, Inc. Fibrinogen based adhesive
EP0534178B1 (de) * 1991-09-27 2001-04-18 Omrix Biopharmaceuticals S.A. Verbesserter Gewebekleber, zubereitet aus Kryopräzipitat
US5290918A (en) * 1993-02-23 1994-03-01 Haemacure Biotech Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by acidic precipitation

Also Published As

Publication number Publication date
JP3492694B2 (ja) 2004-02-03
JPH09509183A (ja) 1997-09-16
CA2113660C (en) 2000-05-16
US5395923A (en) 1995-03-07
AU678439B2 (en) 1997-05-29
DE69419324T2 (de) 2000-03-02
AU6151594A (en) 1995-09-11
EP0748337A1 (de) 1996-12-18
NO963602L (no) 1996-10-17
DK0748337T3 (da) 2000-01-17
ES2135564T3 (es) 1999-11-01
RU2130946C1 (ru) 1999-05-27
CA2113660A1 (en) 1994-08-24
ATE181738T1 (de) 1999-07-15
EP0748337B1 (de) 1999-06-30
NO317699B1 (no) 2004-12-06
NO963602D0 (no) 1996-08-28
WO1995023167A1 (en) 1995-08-31

Similar Documents

Publication Publication Date Title
DE69419324D1 (de) Verfahren zur herstellung eines fibrinogen,faktor xiii und fibronectin enthaltenden biologischen klebstoffes
CA2113663A1 (en) Process for the obtention of a biological adhesive made of concentrated coagulation factors by acidic precipitation
US5260420A (en) Concentrate of thrombin coagulable proteins, the method of obtaining same and therapeutical use thereof
AU724715B2 (en) A stabilized mixture comprising fibrinogen
US5589462A (en) Method of preparing a biological adhesive enriched with platelet factors, and application
US4818291A (en) Silk-fibroin and human-fibrinogen adhesive composition
DE60002231D1 (de) Verfahren zur herstellung eines gels von autologen blutplättchen
US5407671A (en) One-component tissue adhesive and a process for the production thereof
FR15C0003I2 (fr) Production de muteines recombinantes du facteur de coagulation sanguine viii dans des lignees de cellules humaines
DE3855921T2 (de) Verfahren und Desoxyribonukleinsäure zur Herstellung von Gewebefaktor-Protein
DE60038312T2 (de) Faktor x-analog mit einer verbesserten fähigkeit, aktiviert zu werden
US20050265989A1 (en) Non-toxic purification and activation of prothrombin and use thereof
DE69430975D1 (de) Verfahren zur Herstellung von Proteinen
EP0823476B1 (de) Verfahren zur Aktivierung von Prothrombin zu Thrombin
DE59309646D1 (de) Verfahren zur Spaltung von Proenzymen
CN1159206A (zh) 由酵母生产和分泌重组血纤维蛋白原
EP0237981A3 (de) Verfahren zur Herstellung eines den Blutgerinnungsfaktor VIII enthaltenden, sterilen Präparates
JP3277227B2 (ja) 血液凝固阻害ペプチドの製造法
JPH11228443A (ja) 新規なプロトロンビンの活性化方法および該方法に基づくトロンビンの製造方法
de Lille llllllllllllllllllllllIlllllwglllllllllIllllllllllllllllllllllllllllllll
Kijkriengkraikul et al. Preparation of thrombin from Human Cryo-removed Plasma using Russell’s Viper Venom Factor X Activator (RVV-X)
HUT58790A (en) Process for producing cultivating medium for cell-cultures

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings